A Dangerous Shortcut Compounded GLP-1 drugs are often marketed as budget-friendly alternatives to FDA-approved medications
At maximum doses, retatrutide has higher rates of nausea (43% vs 31%), vomiting (21% vs 12%), diarrhea (33% vs 23%), and constipation (25% vs 11%) compared to tirzepatide
Retatrutide vs Tirzepatide UK (2026) Research Guide If you are considering trying one of the newer weight loss injections, you are likely to have heard about tirzepatide and retatrutide
Cold sensitivity isn't a direct indicator of medication efficacy, but it often appears when weight loss is happening consistently
However, this is not particularly true for women at midlife
Symptoms That Suggest a Blood Clot While on Mounjaro: What to Watch For Ask yourself: Have you developed these new signs since starting therapy